Our latest news
Award of DNA Sequencing Tender
21 December 2010
Source BioScience has been selected as a preferred supplier of DNA Sequencing by RCUK Shared Services Centre Ltd (RCUK) following a competitive tender.
Source BioScience acquires imaGenes GmbH, Berlin, Germany
01 December 2010
The Board of Source BioScience is delighted to announce the acquisition of the entire issued share capital of imaGenes GmbH of Berlin, Germany for a total consideration of �2.0 million payable in cash.
Source BioScience provides Interim Management Statement
16 November 2010
The Company today provides its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rules, relating to the period from 1 July 2010 to 16 November 2010.
Source BioScience to offer KRAS and BRAF mutation status testing in Ireland
03 November 2010
Source BioScience is delighted to announce the launch of KRAS and BRAF mutation status testing from our Dublin based laboratory from 8th November 2010. This provision will result in customers based in Ireland receiving a better service and faster turnaround time for these diagnostic tests. This, in turn, will enable clinicians to determine the most appropriate treatment regime and patients to receive more targeted and effective drug therapies. Source BioScience is the first laboratory to offer this service in Ireland and demonstrates our continued commitment to provide high quality diagnostic testing for the Irish healthcare community.The Company became the first commercial service provider to establish a sequencing laboratory in Ireland with the opening of its Dublin facility in January this year.
Source BioScience attendance at ESMO Conference in Milan
06 October 2010
Dr Jackie Rodgers, Head of Pharma Biotech Business Development, Worldwide, for Source BioScience, the Nottingham, UK based healthcare and biotechnology company, will be attending the 2010 European Society for Medical Oncology conference in Milan, 8-12 October 2010. Dr Rodgers will be presenting a poster entitled Routine detection of BRAF and NRAS mutations in FFPE tissue by pyrosequencing.Dr Rodgers would be pleased to hear from companies wishing to discuss how Source BioScience could be of assistance in this area, and can be contacted via email � email@example.com or firstname.lastname@example.org.
Source BioScience launches new Life Sciences website
07 September 2010
The Company is delighted to announce the launch of its new, enhanced website encompassing its entire spectrum of life science activities - www.lifesciences.sourcebioscience.com